Opinion/decision on a Paediatric investigation plan (PIP): Ultomiris, ravulizumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Renal and urinary disorders, PIP number

Opinion/decision on a Paediatric investigation plan (PIP): Ultomiris, ravulizumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Renal and urinary disorders, PIP number: P/0387/2024